Dexamethasone in Patients Hospitalized for COVID-19 Product: — Science Table Drug Interventions Treatments covid19-sciencetable.ca Last Updated: August 12, 2020
Dexamethasone in the Treatment of Hospitalized Patients With COVID-19: A Critical Appraisal of the RECOVERY Study Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: July 24, 2020 Also available in Français
COVID-19 Testing – Evidence and Best Practices Product: — Evidence Synthesis Network Serological Testing Signs & Symptoms Testing & Tracing esnetwork.ca Last Updated: June 25, 2020
Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: June 23, 2020 Also available in Français
Health Technology Update, Issue 27 Product: — Canadian Agency for Drugs and Technologies in Health Future Planning New Technology covid.cadth.ca Last Updated: June 5, 2020 Also available in Français
Incremental Benefit of Using a History of Sudden Loss of Taste (Ageusia) And/Or Smell (Anosmia) in Symptom Screening for COVID-19 Product: — Evidence Synthesis Network Less Common Signs & Symptoms Signs & Symptoms Testing & Tracing Tracing esnetwork.ca Last Updated: May 28, 2020
Methoxyflurane for Acute Pain: Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: May 25, 2020 Also available in Français
Barriers Vulnerable Populations Face Regarding Adherence to COVID‑19 Public Health Measures Product: — Evidence Synthesis Network Barriers to Access Health Inequities Vulnerable Groups esnetwork.ca Last Updated: May 24, 2020